Word: oncologist
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...Mikey” J. Friedman ’11 could be found singing “Hakuna Matata,” playing with the protein modeling computer program Pymol, or coming up with some harebrained scheme to entertain and distract his friends, they said. The aspiring oncologist passed away in early October at the age of 19, bringing an end to his four-and-a-half year battle with desmoplastic small round cell tumor, a rare and aggressive form of cancer. Friends and family said that Friedman exuded brightness—both in his intellect and his personality. His optimism...
Joining Hands Many scientists and theologians who study these matters advocate a system in which both pastoral and medical care are offered as parts of a whole. If a woman given a diagnosis of breast cancer is already offered the services of an oncologist, a psychologist and a reconstructive surgeon, why shouldn't her doctor discuss her religious needs with her and include a pastor in the mix if that would help...
...live in a culture where I think science, the evidence of science, trumps the evidence of faith. If you give a drug that's supposed to work in six months, and three years later you get a remission, that's called delayed effect. And I've said to my oncologist colleagues, Why is that not a miracle? What evidence do you have, because you have no evidence that this is delayed effect--it's just what you're calling it. Tell me that that's not a miracle...
...contributions to oncology at Harvard, and said yesterday that his leadership and mentorship would be missed. “He was very knowledgeable, a great collaborator, and a great friend, and hopefully still will be,” said Leonard I. Zon, an HMS hematologist and oncologist who collaborated with Gilliland through the Howard Hughes Medical Institute and the Harvard Stem Cell Institute. David Scadden, the director of the Stem Cell Institute, yesterday praised Gilliland as “one of the leading lights in academic medicine.” “He made critical discoveries about the genetics...
...Roman Chelbowski, lead author of the current study and a medical oncologist at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, disagrees. He says the rapid decline in cancer rates was due not only to an overall drop in breast-cancer risk, but also to the withdrawal of excess estrogen, which may actually have served as a treatment for tiny, preclinical breast cancers. "When you change from a high- to a low-estrogen environment, it's like giving breast cancer treatment," he says. "These are preclinical cancers that are below the level of detection, and that accounts...